Elisa Capture Assay

Lab Reagents

Assay Elisa Laboratories manufactures the elisa capture assay reagents distributed by Genprice. The Elisa Capture Assay reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Assay elisa. Other Elisa products are available in stock. Specificity: Elisa Category: Capture Group: Assay

Assay information

Albumin (Capture / Detection) Antibody

abx019293-1mg 1 mg
EUR 551

Albumin (Capture / Detection) Antibody

abx019294-1mg 1 mg
EUR 551

Fetal Fibronectin (Capture) Antibody

abx019299-1mg 1 mg
EUR 620

Fetal Fibronectin (Capture) Antibody

abx019301-1mg 1 mg
EUR 620

SCCA1 (Capture / Detection) Antibody

abx019308-1mg 1 mg
EUR 662

SCCA1 (Capture / Detection) Antibody

abx019309-1mg 1 mg
EUR 662

Anti-Canine Coronavirus (Capture) Antibody

A2069-100 100 µg
EUR 338

Anti-CK-MB Capture Antibody

A2088-100 100 µg
EUR 348

Anti-Lp-PLA2 Capture Antibody

A2094-100 100 µg
EUR 363

anti-Protein A Capture Antibody

I061 1 mg
EUR 1066
Description: anti-Protein A Capture Antibody by Cygnus Technologies is available in Europe via Gentaur.

Alpha-fetoprotein, AFP (Capture) Antibody

abx019291-1mg 1 mg
EUR 523

ExoMS Total Protein Capture Kit

EXOMS120A-8 8 reactions
EUR 477

Avian Influenza A Nucleoprotein Antigen Capture ELISA Kit

DEIA2026 2 x 96T
EUR 1295
Description: This kit is a highly sensitive and specific enzyme immunoassay for the detection of Influenza A nucleoprotein antigen in complex sample matrices derived from both human and veterinary sources.

Methylamp Methylated DNA Capture (MeDIP) Kit

P-1015 48 Reactions
EUR 875.05
Description: Ask the seller for details

Cannabinoid (THC)-HRP Antigen (AG310 (capture))

VAng-Cr3668-1mg 1 mg
EUR 806
Description: Cannabinoid (THC)-HRP Antigen, matched pairs: AG310 (capture); Used for ELISA.

Cannabinoid (THC)-HRP Antigen (AG309 (capture))

VAng-Cr3669-1mg 1 mg
EUR 738
Description: Cannabinoid (THC)-HRP Antigen, matched pairs: AG309 (capture); Linking Position: Position 8; Used for ELISA.

Dengue Virus IgM µ-capture ELISA Kit (Human) (OKNA00132)

OKNA00132 96 Wells
EUR 421
Description: Description of target: Dengue fever, also known as breakbone fever, is an infectious tropical disease caused by the dengue virus andtransmitted by mosquitoes. Dengue fever virus (DENV) is a virus of the family Flaviviridae, genus Flavivirus and contains a single-stranded RNA genome with positive polarity. There are four serotypes of the virus, which are referred to as DENV-1, DENV-2, DENV-3 and DENV-4.The geographical distribution is around the equator, particularly Latin America, Central Africa, India, Southeast Asia, Western Pacific and South of the USA.Dengue viruses are transmitted to humans through the bites of infective female yellow fever mosquitoes (Stegomyia aegypti, formerly Aedes aegypti). The mosquitoes generally acquire the virus while feeding on the blood of an infected person. After virus incubation for eight to ten days, an infected mosquito is capable, during probing and blood feeding, of transmitting the virus for the rest of its life.Yellow fever mosquitoes are well adapted to living in close proximity to humans, and to feeding off people rather than other vertebrates. They prefer to lay their eggs in artificial water containers, such as flower vases, uncovered barrels, buckets and discarded tires.The incubation period ranges from 3-14 days, but most often it is 4-7 days. Typically, people infected with dengue virus are asymptomatic or only have symptoms of a common cold. The characteristic symptoms of dengue are sudden-onset fever (up to 40 C) with intense headache (especially behind the eyes), and muscle and joint pain. In combination with a skin rash this symptoms are known as the „dengue triad“. This usually lasts 3-7 days. In some patients the disease proceeds to a critical phase. Dengue Hemorrhagic Fever (DHF) or Dengue Shock Syndrome (DSS) occur in less than 5 % of all cases of dengue. About 1-5 % of severe cases are fatal. In individual epidemics the case-fatality rate may reach up to 15 %.Infection with one serotype is believed to produce lifelong immunity to that serotype but only short term protection against the others. Secondary infection with a different serotype may result in severe clinical manifestations. There is no vaccination available.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Reverse Capture Sandwich ELISA ;Sensitivity: Sensitivity is determined as the probability of the assay indicating a positive score in samples with the specific analyte present: > 98%